Medical Properties Trust (NYSE:MPW) was upgraded by J P Morgan Chase & Co from an “underweight” rating to a “neutral” rating in a report released on Friday, MarketBeat Ratings reports. The brokerage currently has a $14.50 price objective on the real estate investment trust’s stock. J P Morgan Chase & Co’s target price suggests a potential upside of 3.65% from the company’s current price.
Several other analysts also recently commented on MPW. ValuEngine raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. KeyCorp reaffirmed a “hold” rating on shares of Medical Properties Trust in a report on Sunday, September 17th. SunTrust Banks reaffirmed a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a report on Friday, November 3rd. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a report on Tuesday, October 24th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a report on Tuesday, August 29th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Medical Properties Trust has a consensus rating of “Buy” and an average target price of $14.32.
Shares of Medical Properties Trust (MPW) traded up $0.23 on Friday, hitting $13.99. 7,214,698 shares of the stock were exchanged, compared to its average volume of 3,124,563. Medical Properties Trust has a 52 week low of $11.90 and a 52 week high of $14.22. The company has a market cap of $5,090.00, a P/E ratio of 10.70, a PEG ratio of 1.84 and a beta of 0.96. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 1.26.
Institutional investors have recently modified their holdings of the business. Ffcm LLC acquired a new stake in Medical Properties Trust in the 3rd quarter worth about $116,000. IFP Advisors Inc raised its stake in Medical Properties Trust by 12.1% in the 2nd quarter. IFP Advisors Inc now owns 10,102 shares of the real estate investment trust’s stock worth $130,000 after purchasing an additional 1,093 shares in the last quarter. Blair William & Co. IL acquired a new stake in Medical Properties Trust in the 2nd quarter worth about $132,000. Mcmillion Capital Management Inc. acquired a new stake in Medical Properties Trust in the 3rd quarter worth about $137,000. Finally, Janus Henderson Group PLC acquired a new stake in Medical Properties Trust in the 2nd quarter worth about $136,000. Institutional investors and hedge funds own 81.35% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Medical Properties Trust (MPW) Upgraded at J P Morgan Chase & Co” was reported by American Banking and Market News and is owned by of American Banking and Market News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/15/medical-properties-trust-mpw-upgraded-at-j-p-morgan-chase-co.html.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
